Susan M. Reverby

Learn More
Is it good medical practice for physicians to “eyeball” a patient’s race when assessing their medical status or even to ask them to identify their race? This question was captured in a 2005 episode of “House M.D.,” Fox television’s medical drama. In the episode, a black patient with heart disease refuses a hospital physician’s prescription for what is(More)
Your use of the JSTOR archive indicates your acceptance of JSTOR's Terms and Conditions of Use, available at http://www.jstor.org/page/info/about/policies/terms.jsp. JSTOR's Terms and Conditions of Use provides, in part, that unless you have obtained prior permission, you may not download an entire issue of a journal or multiple copies of articles, and you(More)
A t least two dozen companies now market “genetic ancestry tests” to help consumers reconstruct their family histories and determine the geographic origins of their ancestors. More than 460,000 people have purchased these tests over the past 6 years (1), and public interest is still skyrocketing (1–4). Some scientists support this enterprise because it(More)
Since 1972 the word "Tuskegee" has functioned as a metaphor for racism, paternalism, and deadly deception in government-sponsored medical research. There remain new lessons to be considered. We must understand how concepts of race become spoken and written about and then embedded in science that has racist implications. We have to consider how the(More)
To the Editor: We are a group of physicians, bioethicists, and scholars in allied fields who agree with the Office for Human Research Protections (OHRP) that the informed-consent documents that were used in the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT) were seriously inadequate.1 The aims of the SUPPORT study were(More)